Effect of the Microenvironment on Mesenchymal Stem Cell Paracrine Signaling: Opportunities to Engineer the Therapeutic Effect

Stem Cells and Development

Volumn 26, Issue 9, 2017, Pages 617-631

  Kusuma, Gina D ^a   Carthew, James ^a   Lim, Rebecca ^a,b   Frith, Jessica E ^a  

^a MONASH UNIVERSITY   (Australia)

^b HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Exosomes; Mesenchymal stem cell; Microenvironment; Paracrine signaling; Tissue engineering

Indexed keywords

GROWTH FACTOR; OXYGEN;

BONE INJURY; CARDIOVASCULAR DISEASE; CARTILAGE INJURY; CELL GROWTH; CELL NUCLEUS; CELL ORGANELLE; CELL THERAPY; CHEMICAL CUE; CYTOPLASM; EXOSOME; FIBROSIS; GENE CONTROL; HUMAN; MECHANICAL STIMULATION; MECHANICS; MECHANOTRANSDUCTION; MEMBRANE MICROPARTICLE; MESENCHYMAL STEM CELL; NONHUMAN; OXYGEN TENSION; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW; SECRETOME; THERAPY EFFECT; TISSUE REGENERATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; PROCEDURES; TISSUE ENGINEERING; TUMOR MICROENVIRONMENT;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELLULAR MICROENVIRONMENT; EXTRACELLULAR VESICLES; HUMANS; MECHANOTRANSDUCTION, CELLULAR; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; PARACRINE COMMUNICATION; TISSUE ENGINEERING;

EID: 85018267276     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2016.0349     Document Type: Review

References (119)

1. Daley GQ and DT Scadden. (2008). Prospects for stem cell-based therapy. Cell 132:544-548.
2. Hsiao ST-F, A Asgari, Z Lokmic, R Sinclair, GJ Dusting, SY Lim and RJ Dilley. (2012). Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, dermal tissue. Stem Cells Dev 21:2189-2203.
3. Konala VBR, MK Mamidi, R Bhonde, AK Das, R Pochampally and R Pal. (2016). The current landscape of the mesenchymal stromal cell secretome: A new paradigm for cell-free regeneration. Cytotherapy 18:13-24.
4. da Silva Meirelles L, AM Fontes, DT Covas and AI Caplan. (2009). Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20:419-427.
5. de Girolamo L, E Lucarelli, G Alessandri, MA Avanzini, ME Bernardo, E Biagi, AT Brini, G D'Amico, F Fagioli, et al. (2013). Mesenchymal stem/stromal cells: A new cells as drugs' paradigm. Efficacy and critical aspects in cell therapy. Curr Pharm Des 19:2459-2473.
6. Pittenger MF. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
7. Erices A, P Conget and JJ Minguell. (2000). Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109:235-242.
8. Jiang Y, BN Jahagirdar, RL Reinhardt, RE Schwartz, CD Keene, XR Ortiz-Gonzalez, M Reyes, T Lenvik, T Lund, et al. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49.
9. Gronthos S, M Mankani, J Brahim, PG Robey and S Shi. (2000). Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA 97:13625-13630.
10. Gucciardo L, R Lories, N Ochsenbein-Kolble, E Done, A Zwijsen and J Deprest. (2009). Fetal mesenchymal stem cells: Isolation, properties and potential use in perinatology and regenerative medicine. BJOG 116:166-172.
11. Manini I, L Gulino, B Gava, E Pierantozzi, C Curina, D Rossi, A Brafa, C D'Aniello and V Sorrentino. (2011). Multi-potent progenitors in freshly isolated and cultured human mesenchymal stem cells: A comparison between adipose and dermal tissue. Cell Tissue Res 344:85-95.
12. Kusuma GD, MH Abumaree, MD Pertile, AV Perkins, SP Brennecke and B Kalionis. (2016). Mesenchymal stem/stromal cells derived from a reproductive tissue niche under oxidative stress have high aldehyde dehydrogenase activity. Stem Cell Rev Reports 12:285-297.
13. Kusuma GD, D Menicanin, S Gronthos, U Manuelpillai, MH Abumaree, MD Pertile, SP Brennecke and B Kalionis. (2015). Ectopic bone formation by mesenchymal stem cells derived from human term placenta and the decidua. PLoS One 10:e0141246.
14. Meirelles L D S, PC Chagastelles and NB Nardi. (2006). Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119:2204-2213.
15. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
16. Frith JE, AR Cameron, DJ Menzies, P Ghosh, DL Whitehead, S Gronthos, ACW Zannettino and JJ Cooper-White. (2013). An injectable hydrogel incorporating mesenchymal precursor cells and pentosan polysulphate for intervertebral disc regeneration. Biomaterials 34:9430-9440.
17. Arthur A, A Zannettino and S Gronthos. (2009). The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J Cell Physiol 218:237-245.
18. Karam JP, C Muscari and CN Montero-Menei. (2012). Combining adult stem cells and polymeric devices for tissue engineering in infarcted myocardium. Biomaterials 33:5683-5695.
19. Kim J, WG Bae, HW Choung, KT Lim, H Seonwoo, HE Jeong, KY Suh, NL Jeon, PH Choung and JH Chung. (2014). Multiscale patterned transplantable stem cell patches for bone tissue regeneration. Biomaterials 35:9058-9067.
20. Dahlin RL, LA Kinard, J Lam, CJ Needham, S Lu, FK Kasper and AG Mikos. (2014). Articular chondrocytes and mesenchymal stem cells seeded on biodegradable scaffolds for the repair of cartilage in a rat osteochondral defect model. Biomaterials 35:7460-7469.
21. Galderisi U and A Giordano. (2012). The gap between the physiological and therapeutic roles of mesenchymal stem cells. Med Res Rev 29:1292-1327.
22. Minguell JJ, C Allers and GP Lasala. (2013). Mesenchymal stem cells and the treatment of conditions and diseases: The less glittering side of a conspicuous stem cell for basic research. Stem Cells Dev 22:193-203.
23. Karp JM and GS Leng Teo. (2009). Mesenchymal stem cell homing: The devil is in the details. Cell Stem Cell 4:206-216.
24. Wagner J, T Kean, R Young, JE Dennis and AI Caplan. (2009). Optimizing mesenchymal stem cell-based therapeutics. Curr Opin Biotechnol 20:531-536.
25. Freyman T, G Polin, H Osman, J Crary, M Lu, L Cheng, M Palasis and RL Wilensky. (2006). A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 27:1114-1122.
26. Park CW, K-S Kim, S Bae, HK Son, P-K Myung, HJ Hong and H Kim. (2009). Cytokine secretion profiling of human mesenchymal stem cells by antibody array. Int J Stem Cells 2:59-68.
27. Caplan AI and D Correa. (2011). The MSC: An injury drugstore. Cell Stem Cell 9:11-15.
28. Gnecchi M, P Danieli, G Malpasso and MC Ciuffreda. (2016). Paracrine mechanisms of mesenchymal stem cells in tissue repair. In Mesenchymal Stem Cells: Methods and Protocols. Gnecchi M, ed. Springer, New York, pp 123-146.
29. Maguire G. (2013). Stem cell therapy without the cells. Commun Integr Biol 6:e26631.
30. Haynesworth SE, MA Baber and AI Caplan. (1996). Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL-1 alpha. J Cell Physiol 166:585-592.
31. Patschan D, M Plotkin and MS Goligorsky. (2006). Therapeutic use of stem and endothelial progenitor cells in acute renal injury: Ca ira. Curr Opin Pharmacol 6:176-183.
32. Tögel F, Z Hu and K Weiss. (2005). Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Ren Physiol 289:31-42.
33. Gnecchi M, H He, N Noiseux, OD Liang, L Zhang, F Morello, H Mu, LG Melo, RE Pratt, JS Ingwall and VJ Dzau. (2006). Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 20:661-669.
34. Timmers L, SK Lim, F Arslan, JS Armstrong, IE Hoefer, PA Doevendans, JJ Piek, RM El Oakley, A Choo, et al. (2008). Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res 1:129-137.
35. Gnecchi M, Z Zhang, A Ni and VJ Dzau. (2008). Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103:1204-1219.
36. Kuraitis D, C Giordano, M Ruel, A Musarò and EJ Suuronen. (2012). Exploiting extracellular matrix-stem cell interactions: A review of natural materials for therapeutic muscle regeneration. Biomaterials 33:428-443.
37. Khubutiya MS, AV Vagabov, AA Temnov and AN Sklifas. (2014). Paracrine mechanisms of proliferative, anti-apoptotic and anti-inflammatory effects of mesenchymal stromal cells in models of acute organ injury. Cytotherapy 16:579-585.
38. Carayon K, K Chaoui, E Ronzier, I Lazar, J Bertrand-Michel, V Roques, S Balor, F Terce, A Lopez, L Salomé and E Joly. (2011). Proteolipidic composition of exosomes changes during reticulocyte maturation. J Biol Chem 286:34426-34439.
39. Anderson JD, HJ Johansson, CS Graham, M Vesterlund, MT Pham, CS Bramlett, EN Montgomery, MS Mellema, RL Bardini, et al. (2016). Comprehensive proteomic analysis of mesenchymal stem cell exosomes reveals modulation of angiogenesis via nuclear factor-kappaB signaling. Stem Cells 34:601-613.
40. Raposo G and W Stoorvogel. (2013). Extracellular vesicles: Exosomes, microvesicles, friends. J Cell Biol 200:373-383.
41. Xu R, DW Greening, H-J Zhu, N Takahashi and RJ Simpson. (2016). Extracellular vesicle isolation and characterization: Toward clinical application. J Clin Invest 126:1152-1162.
42. Baglio SR, K Rooijers, D Koppers-Lalic, FJ Verweij, M Pérez Lanzón, N Zini, B Naaijkens, F Perut, HW Niessen, N Baldini and DM Pegtel. (2015). Human bone marrowand adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species. Stem Cell Res Ther 6:127.
43. Lobb RJ, M Becker, SW Wen, CSF Wong, AP Wiegmans, A Leimgruber and A Möller. (2015). Optimized exosome isolation protocol for cell culture supernatant and human plasma. J Extracell Vesicles 1:1-11.
44. Lener T, M Gioma, L Aigner, V Börger, E Buzas, G Camussi, N Chaput, D Chatterjee, FA Court, et al. (2015). Applying extracellular vesicles based therapeutics in clinical trials-an ISEV position paper. J Extracell Vesicles 4:1-31.
45. Lötvall J, AF Hill, F Hochberg, EI Buzás, D Di Vizio, C Gardiner, YS Gho, IV Kurochkin, S Mathivanan, et al. (2014). Minimal experimental requirements for definition of extracellular vesicles and their functions: A position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles 3:26913.
46. Sinclair KA, S Yerkovich, P Hopkins and D Chambers. (2016). 20-Human lung-derived mesenchymal stromal cells donate cytoplasmic content to bronchial epithelium through microtubules, tunnelling nanotubes, gap junctions and microvesicles. Cytotherapy 18:S13.
47. Matula Z, A Németh, P Lorincz, A Szepesi, B Anna, EI Buzás, P Low, K Német, F Uher and V Urbán. (2016). The role of extracellular vesicle and tunneling nanotubemediated intercellular cross-talk between mesenchymal stem cells and human peripheral T cells. Stem Cells Dev 25:1818-1832.
48. Furuta T, S Miyaki, H Ishitobi, T Ogura, Y Kato, N Kamei, K Miyado, Y Higashi and M Ochi. (2012). Mesenchymal stem cell-derived exosomes promote fracture healing in a mouse model. Stem Cells Transl Med 5:1-11.
49. Wen S, M Dooner, Y Cheng, E Papa, M Del Tatto, M Pereira, Y Deng, L Goldberg, J Aliotta, et al. (2016). Mesenchymal stromal cell derived extracellular vesicles rescue radiation damage to murine marrow hematopoietic cells. Leukemia 30:1-39.
50. Zhang S, WC Chu, RC Lai, SK Lim, JHP Hui and WS Toh. (2016). Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration. Osteoarthritis Cartilage 24:6-11.
51. Arslan F, RC Lai, MB Smeets, L Akeroyd, A Choo, ENE Aguor, L Timmers, HV van Rijen, PA Doevendans, et al. (2013). Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res 10:301-312.
52. Feng Y, W Huang, M Wani, X Yu and M Ashraf. (2014). Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PLoS One 9:e88685.
53. Yu B, HW Kim, M Gong, J Wang, RW Millard, Y Wang, M Ashraf and M Xu. (2015). Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection. Int J Cardiol 182:349-360.
54. Wang B, K Yao, BM Huuskes, H-H Shen, J Zhuang, C Godson, EP Brennan, JL Wilkinson-Berka, AF Wise and SD Ricardo. (2016). Mesenchymal stem cells deliver exogenous microRNA-let7c via exosomes to attenuate renal fibrosis. Mol Ther 24:1290-1301.
55. Choi M, T Ban and T Rhim. (2014). Therapeutic use of stem cell transplantation for cell replacement or cytoprotective effect of microvesicle released from mesenchymal stem cell. Mol Cells 37:133-139.
56. Hyun J, S Wang, J Kim, GJ Kim and Y Jung. (2015). MicroRNA125b-mediated Hedgehog signaling influences liver regeneration by chorionic plate-derived mesenchymal stem cells. Sci Rep 5:14135.
57. Li T, Y Yan, B Wang, H Qian, X Zhang, L Shen, M Wang, Y Zhou, W Zhu, W Li and W Xu. (2012). Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev 22:845-854.
58. Kalra H, GPC Drummen and S Mathivanan. (2016). Focus on extracellular vesicles: Introducing the next small big thing. Int J Mol Sci 17:170.
59. Iavello A, VSL Frech, C Gai, MC Deregibus, PJ Quesenberry and G Camussi. (2016). Role of Alix in miRNA packaging during extracellular vesicle biogenesis. Int J Mol Med 37:958-966.
60. Baietti MF, Z Zhang, E Mortier, A Melchior, G Degeest, A Geeraerts, Y Ivarsson, F Depoortere, C Coomans, et al. (2012). Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 14:677-685.
61. Biancone L, S Bruno, MC Deregibus, C Tetta and G Camussi. (2012). Therapeutic potential of mesenchymal stem cell-derived microvesicles. Nephrol Dial Transplant 27:3037-3042.
62. del Rio A, R Perez-Jimenez, R Liu, P Roca-Cusachs, JM Fernandez and MP Sheetz. (2009). Stretching single talin rod molecules activates vinculin binding. Science 323: 638-641.
63. Tamada M, MP Sheetz and Y Sawada. (2004). Activation of a signaling cascade by cytoskeleton stretch. Dev Cell 7:709-718.
64. Sawada Y, M Tamada, BJ Dubin-Thaler, O Cherniavskaya, R Sakai, S Tanaka and MP Sheetz. (2006). Force sensing by mechanical extension of the Src family kinase substrate p130Cas. Cell 127:1015-1026.
65. Burridge K and M Chrzanowska-Wodnicka. (1996). Focal adhesions, contractility, signaling. Annu Rev Cell Dev Biol 12:463-519.
66. McBeath R, DM Pirone, CM Nelson, K Bhadriraju and CS Chen. (2004). Cell shape, cytoskeletal tension, RhoA regulate stem cell lineage commitment. Dev Cell 6:483-495.
67. Chrzanowska-Wodnicka M and K Burridge. (1996). Rhostimulated contractility drives the formation of stress fibers and focal adhesions. J Cell Biol 133:1403-1415.
68. Miyauchi T, T Yanagida and Y Sako. (2007). Rho small GTPase regulates the stability of individual focal adhesions: A FRET-based visualization of GDP/GTP exchange on small GTPases. Biophysics (Oxf) 28:63-73.
69. Li C, G Zhen, Y Chai, L Xie, JL Crane, E Farber, CR Farber, X Luo, P Gao, X Cao and M Wan. (2016). RhoA determines lineage fate of mesenchymal stem cells by modulating CTGF-VEGF complex in extracellular matrix. Nat Commun 7:11455.
70. Sims JR, S Karp and DE Ingber. (1992). Altering the cellular mechanical force balance results in integrated changes in cell, cytoskeletal and nuclear shape. J Cell Sci 103:1215-1222.
71. Maniotis AJ, CS Chen and DE Ingber. (1997). Demonstration of mechanical connections between integrins, cytoskeletal filaments, nucleoplasm that stabilize nuclear structure. Proc Natl Acad Sci USA 94:849-854.
72. Starr DA and HN Fridolfsson. (2010). Interactions between nuclei and the cytoskeleton are mediated by SUNKASH nuclear-envelope bridges. Annu Rev Cell Dev Biol 26:421-444.
73. Lammerding J, PC Schulze, T Takahashi, S Kozlov, T Sullivan, RD Kamm, CL Stewart and RT Lee. (2004). Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J Clin Invest 113:370-378.
74. Lammerding J, J Hsiao, PC Schulze, S Kozlov, CL Stewart and RT Lee. (2005). Abnormal nuclear shape and impaired mechanotransduction in emerin-deficient cells. J Cell Biol 170:781-791.
75. Ho CY, DE Jaalouk, MK Vartiainen and J Lammerding. (2013). Lamin A/C and emerin regulate MKL1-SRF activity by modulating actin dynamics. Nature 497:507-511.
76. Zhang M, Y Liao and B Lönnerdal. (2016). EGR-1 is an active transcription factor in TGF-b2-mediated small intestinal cell differentiation. J Nutr Biochem 37:101-108.
77. Pires AO, B Mendes-Pinheiro, FG Teixeira, SI Anjo, S Ribeiro-Samy, ED Gomes, SC Serra, NA Silva, B Manadas, N Sousa and AJ Salgado. (2016). Unveiling the differences of secretome of human bone marrow mesenchymal stem cells, adipose tissue derived stem cells and human umbilical cord perivascular cells: A proteomic analysis. Stem Cells Dev 25:1073-1083.
78. Blaber SP, RA Webster, CJ Hill, EJ Breen, D Kuah, G Vesey and BR Herbert. (2012). Analysis of in vitro secretion profiles from adipose-derived cell populations. J Transl Med 10:172.
79. Amable PR, MVT Teixeira, RBV Carias, JM Granjeiro and R Borojevic. (2014). Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly. Stem Cell Res Ther 5:53.
80. Wang B, YW Lee, B Huang, J Zhang, T Wu, X Jiang, R Wang and G Li. (2016). Secretome of human fetal mesenchymal stem cell ameliorates replicative senescence. Stem Cells Dev 25:1755-1766.
81. Pandey AC, JA Semon, D Kaushal, RP O'Sullivan, J Glowacki, JM Gimble and BA Bunnell. (2011). Micro-RNA profiling reveals age-dependent differential expression of nuclear factor kB and mitogen-activated protein kinase in adipose and bone marrow-derived human mesenchymal stem cells. Stem Cell Res Ther 2:49.
82. Ganguly P, JJ El-Jawhari, PV Giannoudis, AN Burska, F Ponchel and EA Jones. (2017). Age related changes in bone marrow mesenchymal stromal cells: A potential impact on osteoporosis and osteoarthritis development. Cell Transplant [Epub ahead of print]; DOI: 10.3727/096368917X694651.
83. Billing AM, H Ben Hamidane, SS Dib, RJ Cotton, AM Bhagwat, P Kumar, S Hayat, NA Yousri, N Goswami, et al. (2016). Comprehensive transcriptomic and proteomic characterization of human mesenchymal stem cells reveals source specific cellular markers. Sci Rep 6:21507.
84. Panfoli I, S Ravera, M Podesta, C Cossu, L Santucci, M Bartolucci, M Bruschi, D Calzia, F Sabatini, et al. (2016). Exosomes from human mesenchymal stem cells conduct aerobic metabolism in term and preterm newborn infants. FASEB J 30:1416-1424.
85. Arufe MC, A De la Fuente, J Mateos, I Fuentes, FJ De Toro and FJ Blanco. (2011). Analysis of the chondrogenic potential and secretome of mesenchymal stem cells derived from human umbilical cord stroma. Stem Cells Dev 20:1199-1212.
86. Choi YA, J Lim, KM Kim, B Acharya, JY Cho, YC Bae, HI Shin, SY Kim and EK Park. (2010). Secretome analysis of human BMSCs and identification of SMOC1 as an important ECM protein in osteoblast differentiation. J Proteome Res 9:2946-2956.
87. Hemmingsen M, S Vedel, P Skafte-Pedersen, D Sabourin, P Collas, H Bruus and M Dufva. (2013). The role of paracrine and autocrine signaling in the early phase of adipogenic differentiation of adipose-derived stem cells. PLoS One 8:e63638.
88. Frith JE, DM Titmarsh, H Padmanabhan and JJ Cooper-White. (2013). Microbioreactor array screening of wnt modulators and microenvironmental factors in osteogenic differentiation of mesenchymal progenitor cells. PLoS One 8:e82931.
89. Ren G, L Zhang, X Zhao, G Xu, Y Zhang, AI Roberts, RC Zhao and Y Shi. (2008). Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2:141-150.
90. Li C, G Li, M Liu, T Zhou and H Zhou. (2016). Paracrine effect of inflammatory cytokine-activated bone marrow mesenchymal stem cells and its role in osteoblast function. J Biosci Bioeng 121:213-219.
91. Rodriguez T, A Saldias, M Irigo, J Zamora, M Perone and R Dewey. (2014). Effect of TGF-b1 stimulation on the secretome of human adipose-derived mesenchymal stromal cells. Stem Cells Transl Med 4:481-488.
92. Nemeth K, A Keane-myers, M Jared, DD Metcalfe, JD Gorham, VG Bundoc, MG Hodges, I Jelinek, S Madala, et al. (2010). Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweedinduced asthma. Erratum in Proc Natl Acad Sci USA 107:8041.
93. Ti D, H Hao, C Tong, J Liu, L Dong, J Zheng, Y Zhao, H Liu, X Fu and W Han. (2015). LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosomeshuttled let-7b. J Transl Med 13:308.
94. Holzwarth C, M Vaegler, F Gieseke, SM Pfister, R Handgretinger, G Kerst and I Muller. (2010). Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells. BMC Cell Biol 11:11.
95. Hung S-P, JH Ho, YR Shih, T Lo and OK Lee. (2012). Hypoxia promotes proliferation and osteogenic differentiation potentials of human mesenchymal stem cells. J Orthop Res 30:260-266.
96. Teixeira FG, KM Panchalingam, SI Anjo, B Manadas, R Pereira, N Sousa, AJ Salgado and LA Behie. (2015). Do hypoxia/normoxia culturing conditions change the neuroregulatory profile of Wharton Jelly mesenchymal stem cell secretome Stem Cell Res Ther 6:133.
97. Paquet J, M Deschepper, A Moya, D Logeart-Avramoglou, C Boisson-Vidal and H Petite. (2015). Oxygen tension regulates human mesenchymal stem cell paracrine functions. Stem Cells Transl Med 4:809-821.
98. An HY, HS Shin, JS Choi, HJ Kim, JY Lim and YM Kim. (2015). Adipose mesenchymal stem cell secretome modulated in hypoxia for remodeling of radiation-induced salivary gland damage. PLoS One 10:1-17.
99. Saraswati S, Y Guo, J Atkinson and PP Young. (2015). Prolonged hypoxia induces monocarboxylate transporter-4 expression in mesenchymal stem cells resulting in a secretome that is deleterious to cardiovascular repair. Stem Cells 33:1333-1344.
100. Li L, S Jin and Y Zhang. (2015). Ischemic preconditioning potentiates the protective effect of mesenchymal stem cells on endotoxin-induced acute lung injury in mice through secretion of exosome. Int J Clin Exp Med 8:3825-3832.
101. Ylöstalo JH, TJ Bartosh, K Coble and DJ Prockop. (2012). Human mesenchymal stem/stromal cells cultured as spheroids are self-activated to produce prostaglandin E2 that directs stimulated macrophages into an anti-inflammatory phenotype. Stem Cells 30:2283-2296.
102. Bartosh TJ, JH Ylöstalo, A Mohammadipoor, N Bazhanov, K Coble, K Claypool, RH Lee, H Choi and DJ Prockop. (2010). Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci USA 107:13724-13729.
103. Frith JE, B Thomson and PG Genever. (2010). Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential. Tissue Eng Part C Methods 16:735-749.
104. Ho SS, KC Murphy, BYK Binder, CB Vissers and JK Leach. (2014). Increased survival and function of mesenchymal stem cell spheroids entrapped in instructive alginate hydrogels. Stem Cells Transl Med 5:773-781
105. De Lisio M, T Jensen, RA Sukiennik, HD Huntsman and M Boppart. (2014). Substrate and strain alter the musclederived mesenchymal stem cell secretome to promote myogenesis. Stem Cell Res Ther 5:74.
106. Chaudhuri O, L Gu, D Klumpers, M Darnell, SA Bencherif, JC Weaver, N Huebsch, H-P Lee, E Lippens, GN Duda and DJ Mooney. (2015). Hydrogels with tunable stress relaxation regulate stem cell fate and activity. Nat Mater 15:326-333.
107. Cameron AR, JE Frith and JJ Cooper-White. (2011). The influence of substrate creep on mesenchymal stem cell behaviour and phenotype. Biomaterials 32:5979-5993.
108. Engler AJ, S Sen, HL Sweeney and DE Discher. (2006). Matrix elasticity directs stem cell lineage specification. Cell 126:677-689.
109. Frith JE, RJ Mills and JJ Cooper-White. (2012). Lateral spacing of adhesion peptides influences human mesenchymal stem cell behaviour. J Cell Sci 125:317-327.
110. Wu YN, JBK Law, AY He, HY Low, JHP Hui, CT Lim, Z Yang and EH Lee. (2014). Substrate topography determines the fate of chondrogenesis from human mesenchymal stem cells resulting in specific cartilage phenotype formation. Nanomedicine 10:1507-1516.
111. Tsimbouri P, N Gadegaard, K Burgess, K White, P Reynolds, P Herzyk, R Oreffo and MJ Dalby. (2014). Nanotopographical effects on mesenchymal stem cell morphology and phenotype. J Cell Biochem 115:380-390.
112. Abdeen AA, JB Weiss, J Lee and KA Kilian. (2014). Matrix composition and mechanics direct proangiogenic signaling from mesenchymal stem cells. Tissue Eng Part A 20:2737-2745.
113. Kasper G, N Dankert, J Tuischer, M Hoeft, T Gaber, JD Glaeser, D Zander, M Tschirschmann, M Thompson, G Matziolis and GN Duda. (2007). Mesenchymal stem cells regulate angiogenesis according to their mechanical environment. Stem Cells 25:903-910.
114. Gardner OF, N Fahy, M Alini and MJ Stoddart. (2016). Differences in human mesenchymal stem cell secretomes during chondrogenic induction. Eur Cell Mater 31:221-235
115. Kilian KA, B Bugarija, BT Lahn and M Mrksich. (2010). Geometric cues for directing the differentiation of mesenchymal stem cells. Proc Natl Acad Sci USA 107:4872-4877.
116. Frith JE, P Jaramillo-Ferrada, RJ Mills, AR Cameron, DM Titmarsh, EJ Wolvetang and JJ Cooper-White. (2012). Development of defined culture conditions for expansion of human mesenchymal stromal cells for clinical applications. In: Stem Cells and Cancer Stem Cells, Volume 8: Therapeutic Applications in Disease and Injury. Hayat MA, ed. Springer, Dordrecht, Netherlands, pp 13-26.
117. Swamynathan P, P Venugopal, S Kannan, C Thej, UK Kolkundar, S Bhagwat, M Ta, A Sen Majumdar and S Balasubramanian. (2014). Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton's jelly derived mesenchymal stem cells A comparative study. Stem Cell Res Ther 5:88.
118. de Soure AM, A Fernandes-Platzgummer, CL da Silva and JMS Cabral. (2016). Scalable microcarrier-based manufacturing of mesenchymal stem/stromal cells. J Biotechnol 236:88-109.
119. Zhang J, X Liu, H Li, C Chen, B Hu, X Niu, Q Li, B Zhao, Z Xie and Y Wang. (2016). Exosomes/tricalcium phosphate combination scaffolds can enhance bone regeneration by activating the PI3K/Akt signaling pathway. Stem Cell Res Ther 7:136.